Physical Profile of Cervicogenic Headache: Comparison With Neck Pain and Healthy Controls
20 sierpnia 2026 zaktualizowane przez: fatih bali, Istanbul Medipol University Hospital
A Multidimensional Physical Profile of Cervicogenic Headache: A Cross-Sectional Comparison With Nonspecific Neck Pain and Healthy Controls
The goal of this observational study is to compare physical findings across three adult groups. Cervicogenic headache (CGH) is a headache linked to a problem in the neck. Neck pain may affect posture, muscle function, grip strength, and sensitivity to pressure. Researchers do not know whether CGH has a distinct pattern of these findings.
The main questions are:
- Do posture, grip strength, muscle stiffness, elasticity, and pressure sensitivity differ among the groups?
- Are any differences more closely associated with CGH than with neck pain?
Researchers will compare adults ages 25 through 60. One group will include people with CGH lasting at least three months. Another group will include people with neck pain lasting at least six months. People in the neck pain group will have no headaches. Healthy participants will have no neck pain or headaches.
Researchers will not provide treatment or change participants' usual care. Each participant will complete one study visit lasting about 15 minutes. Participants will:
- Answer short questions about their health and pain
- Stand while researchers measure their head and neck posture
- Squeeze a device that measures grip strength
- Complete brief tests of neck muscle stiffness and elasticity
- Tell researchers when applied pressure first becomes painful
Researchers will compare results across the three groups. The findings may guide future CGH assessment and treatment research.
Przegląd badań
Status
Rekrutacyjny
Typ studiów
Obserwacyjny
Zapisy (Szacowany)
135
Kontakty i lokalizacje
Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.
Kontakt w sprawie studiów
- Nazwa: Fatih Bali, PhD.
- Numer telefonu: +905323937689
- E-mail: fatihbali@hotmail.com
Lokalizacje studiów
-
-
Sefaköy
-
Istanbul, Sefaköy, Turcja (Türkiye), 34433
- Rekrutacyjny
- Medipol Sefaköy Üniversite Hastanesi
-
Kontakt:
- Fatih Bali, PhD.
- Numer telefonu: +905323937689
- E-mail: fatihbali@hotmail.com
-
Kontakt:
- E-mail: fatihbali@hotmail.com
-
-
Kryteria uczestnictwa
Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dorosły
Akceptuje zdrowych ochotników
Tak
Metoda próbkowania
Próbka bez prawdopodobieństwa
Badana populacja
The study population consists of adults aged 25-60 years recruited at the study site in Istanbul, Türkiye.
Participants are classified into three groups according to predefined clinical criteria.
The cervicogenic headache group includes individuals diagnosed by a physician according to the International Classification of Headache Disorders, 3rd edition.
The chronic nonspecific neck pain group includes individuals with neck pain lasting at least 6 months and no headache.
The healthy control group includes individuals without neck pain or headache.
Participants receive no study intervention and complete one questionnaire-based and instrument-based assessment session.
Opis
- Inclusion Criteria:
- Aged 25 to 60 years
- Able to provide written informed consent
- Meeting the criteria for one of the following groups:
- Cervicogenic headache: physician diagnosis according to the International Classification of Headache Disorders, 3rd edition, with symptoms lasting at least 3 months
- Chronic nonspecific neck pain: neck pain lasting at least 6 months without headache
- Healthy control: no neck pain or headache
Exclusion Criteria:
- Receipt of physiotherapy for headache or neck pain during the previous 6 months
- Diagnosis of a headache disorder other than cervicogenic headache, including migraine or tension-type headache, or a diagnosis of trigeminal neuralgia
- History of cervical spine surgery or significant cervical trauma
- Current or previous diagnosis of a tumor or cancer
- Serious cardiovascular, cerebrovascular, hematological, metabolic, neurological, or psychiatric disorder
- Rheumatoid arthritis
- Congenital cervical abnormality
- Cervical spondylolisthesis or cervical instability
- Active infection
- Temporomandibular joint dysfunction
- Dizziness or visual disturbance accompanying headache
- Any clinical red flag suggesting serious cervical pathology
- Pregnancy or breastfeeding
- Upper-extremity injury, surgery, or another condition affecting handgrip strength
- Serious musculoskeletal disorder affecting cervical posture or muscle measurements
- Inability to complete the questionnaire-based or instrument-based assessments
Plan studiów
Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
|---|
|
Cervicogenic Headache Group
Adults aged 25-60 years with cervicogenic headache diagnosed by a physician according to the International Classification of Headache Disorders, 3rd edition (ICHD-3), and symptoms lasting at least 3 months.
Participants undergo one questionnaire-based and instrument-based assessment session.
No intervention is assigned.
|
|
Chronic Nonspescific Neck Pain Group
Adults aged 25-60 years with chronic nonspecific neck pain lasting at least 6 months and no headache.
Participants undergo one questionnaire-based and instrument-based assessment session.
No intervention is assigned.
|
|
Healthy Control Group
Adults aged 25-60 years with no neck pain or headaches.
Participants undergo one questionnaire-based and instrument-based assessment session.
No intervention is assigned.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Bilateral Upper Trapezius Muscle Stiffness
Ramy czasowe: During the single assessment session at enrollment
|
Upper trapezius muscle stiffness will be assessed bilaterally using the MyotonPRO device.
Three consecutive measurements will be obtained at the midpoint between the C7 spinous process and the lateral border of the acromion.
The mean of the three measurements will be used.
Stiffness will be expressed in newtons per meter (N/m), with higher values indicating greater stiffness.
|
During the single assessment session at enrollment
|
|
Bilateral Upper Trapezius Logarithmic Decrement
Ramy czasowe: During the single assessment session at enrollment
|
Upper trapezius logarithmic decrement will be assessed bilaterally using the MyotonPRO device at the same standardized measurement site.
Three consecutive measurements will be obtained on each side, and their mean will be used.
Logarithmic decrement is a dimensionless inverse indicator of tissue elasticity, with lower values indicating greater elasticity.
|
During the single assessment session at enrollment
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Bilateral Handgrip Strength
Ramy czasowe: During the single assessment session at enrollment
|
Bilateral handgrip strength will be measured using a Jamar Hydraulic Hand Dynamometer set to the second handle position.
Participants will perform three maximal contractions with each hand in a standardized seated position.
The highest value for each hand will be recorded in kilograms, with higher values indicating greater handgrip strength.
|
During the single assessment session at enrollment
|
|
Bilateral Upper Trapezius Pressure Pain Threshold
Ramy czasowe: During the single assessment session at enrollment
|
Pressure pain threshold will be measured bilaterally over the upper trapezius using a handheld pressure algometer with a 1-cm² probe.
The measurement site will be the midpoint between the C7 spinous process and the lateral border of the acromion.
Pressure will gradually increase until the participant first reports pain.
Values will be recorded in kg/cm², with higher values indicating a higher pressure pain threshold.
|
During the single assessment session at enrollment
|
|
Bilateral Suboccipital Pressure Pain Threshold
Ramy czasowe: During the single assessment session at enrollment
|
Pressure pain threshold will be measured bilaterally over the suboccipital region using a handheld pressure algometer with a 1-cm² probe.
The measurement site will be located 2 cm lateral to the C2 spinous process.
Pressure will gradually increase until the participant first reports pain.
Values will be recorded in kg/cm², with higher values indicating a higher pressure pain threshold.
|
During the single assessment session at enrollment
|
|
Tragus-to-Wall Distance
Ramy czasowe: During the single assessment session at enrollment
|
Tragus-to-wall distance will be measured in millimeters using a tape measure.
Participants will stand with their heels, sacrum, and thoracic spine resting comfortably against a wall while maintaining a natural head position.
The distance between the wall and the tragus will be recorded.
Greater distances indicate greater forward positioning of the head.
|
During the single assessment session at enrollment
|
|
Craniovertebral Angle
Ramy czasowe: During the single assessment session at enrollment
|
The craniovertebral angle will be measured in degrees using a universal goniometer.
The fulcrum will be positioned over the lateral projection of the C7 spinous process.
The stationary arm will remain parallel to the floor, and the movable arm will point toward the tragus.
Three measurements will be obtained, and their mean will be used.
Smaller angles indicate greater forward head posture.
|
During the single assessment session at enrollment
|
Współpracownicy i badacze
Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.
Współpracownicy
Daty zapisu na studia
Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
21 kwietnia 2026
Zakończenie podstawowe (Szacowany)
1 października 2026
Ukończenie studiów (Szacowany)
1 października 2026
Daty rejestracji na studia
Pierwszy przesłany
17 sierpnia 2026
Pierwszy przesłany, który spełnia kryteria kontroli jakości
17 sierpnia 2026
Pierwszy wysłany (Rzeczywisty)
20 sierpnia 2026
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
21 sierpnia 2026
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
20 sierpnia 2026
Ostatnia weryfikacja
1 sierpnia 2026
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- E-10840098-50.04-2858
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
NIE
Opis planu IPD
Individual participant data will not be shared.
Study findings will be reported only in aggregate form through scientific publications and presentations.
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Nie
Bada produkt urządzenia regulowany przez amerykańską FDA
Nie
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .